Mary Ann Liebert, Inc., publishers

Once broken, a compact fluorescent light bulb continuously releases mercury vapor into the air for weeks to months, and the total amount can exceed safe human exposure levels in a poorly ventilated room

A policy specialist and a healthcare economist both say that the oft-quoted cost of $1.32 billion to bring a new drug to market does not hold up to close scrutiny

Basal insulin analogs have revolutionized diabetes care, and especially the treatment of type 2 diabetes, enabling patients to achieve better control of blood glucose levels while reducing hypoglycemic episodes

The convergence of commercial genomic kits and electronic medical records is helping to drive the healthcare industry’s focus on personalized medicine, reports Genetic Engineering & Biotechnology News (GEN)

Genetic Engineering & Biotechnology News (GEN) will host a Contract Services Summit and Drug Discovery Theater at the Annual BIO International conference in Washington, DC, later this month.

Sophisticated imaging tools and techniques are emerging that make it possible to probe organization and activity of the brain at cellular and molecular levels, leading to a better understanding of complex networks that link brain structure/function.

Many gene therapy strategies designed to deliver a normal copy of a gene to cells carrying a disease-causing genetic mutation rely on a modified virus to transfer the gene product into affected tissues.

Ongoing, intrinsic brain activity that is not task-related accounts for the majority of energy used by the human brain

Disorders of the eye are excellent targets for gene therapy because the ocular environment is readily accessible, relatively easy to monitor, and sequestered from the rest of the body

The field of adolescent and young adult oncology (AYAO) reflects the growing recognition that this group of patients and survivors are not just “old” pediatric patients or “young” adult patients